Cold Agglutinin Disease Drugs Market Size
Market Size in USD Mn
CAGR22.8%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 22.8% |
| Market Concentration | Medium |
| Major Players | Sanofi, Novartis, Incyte Corporation, Apellis Pharmaceuticals, Sobi and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Cold Agglutinin Disease Drugs Market Analysis
The cold agglutinin disease drugs market is estimated to be valued at USD 164.6 Mn in 2025 and is expected to reach USD 693.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 22.8% from 2025 to 2032.
Factors such as the rising prevalence of cold agglutinin disease, growing awareness about the disease, and increasing research and development activities for novel treatment options are expected to drive the demand for cold agglutinin disease drugs during the forecast period.